 | Articles: Drug Trials |
MS Drug Shows Trials Promise
PharmiWeb, 06/26/08
A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial
British Journal of Clinical Pharmacology, 06/26/08
Design of a Phase 1/2 Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Heart Failure
Journal of Cardiac Failure, 06/26/08
Lorus Therapeutics announces that the European Medicines Agency (EMEA) has granted the orphan drug designation to LOR-2040 for the treatment of Acute Myeloid Leukemia (AML)
Corporate News Releases, 06/25/08
Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
Corporate News Releases, 06/24/08
Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
Corporate News Releases, 06/24/08
Sepracor Announces Phase III Data for Eslicarbazepine Acetate Presented at Ninth Eilat Conference on New Anti-Epileptic Drugs
Corporate News Releases, 06/24/08
Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials
Current Medical Research and Opinion, 06/24/08
Hospitalization rates before and after initiation of paliperidone ER in patients with schizophrenia: results from open-label extensions of the US double-blind trials
Current Medical Research and Opinion, 06/24/08
Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors
Current Medical Research and Opinion, 06/24/08
|
 Receive daily email updates on Drug Trials
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
